Moderna (MRNA)

Working Capital Ratio

29.93%

Quarterly · Period ending:

MRNA logo

MRNA Working Capital Ratio

Latest reported29.93%
MRNA Quarterly Working Capital Ratio (54.57% → 29.93%)
High-resolution chart · PNG

MRNA working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
29.9334%
29.3785%
36.9347%
40.5192%
38.2931%
40.6329%
41.6702%
47.2379%
46.5434%
43.1586%
39.6722%
32.9769%
34.1619%
35.743%
32.9028%
28.7458%
25.9225%
25.7597%
28.1446%
16.5751%
13.1802%
25.6972%
26.0188%
45.2313%
75.5907%
53.9459%
62.0156%
59.5025%
55.506%
54.3497%
68.3028%
62.554%
60.1131%
54.566%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.